» Articles » PMID: 31890683

Identification and Performance of Multiple Clinical and Laboratorial Risk Factors for Diagnosis of Cardiac Autonomic Neuropathy in Type 1 Diabetes Patients

Overview
Specialty Endocrinology
Date 2020 Jan 1
PMID 31890683
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The incidence of cardiac autonomic neuropathy (CAN) in patients with type 1 diabetes (T1D) is frequently underestimated. Individuals with T1D and CAN have an increased mortality risk, mainly from cardiovascular causes. The objectives of the present study were to assess the clinical and laboratory characteristics associated with CAN in patients with T1D and verify the ability of multiple clinical factors to help identify patients with this condition.

Methods: 102 patients with T1D were evaluated for CAN using standardized cardiovascular reflex testing. Clinical characteristics were used to compute a numerical score for CAN diagnosis and a ROC curve elaborated for assessment of the best cutoff to predict CAN. This score was then applied to the second sample of 120 patients. The sensitivity, specificity, and positive and negative predictive values were calculated.

Results: Prevalence of CAN was around 35% in the first sample of patients and just below 20% in the second sample. Hypertension, total cholesterol, triglycerides, postprandial sweating, diastolic blood pressure, abnormal right and left 10 g monofilament, retinopathy, and nephropathy were considered independent predictors of CAN. The CAN-score cut-off was 16.88. This yielded a sensitivity of 50%, specificity 73.8%, positive predictive value 22.9%, and negative predictive value 90.5%.

Conclusion: The use of a subset of clinical and laboratory characteristics can be more accessible than the cardiac reflex tests and more accurate than a single isolated characteristic.

Citing Articles

Prevalence and Risk Factors of Cardiovascular Autonomic Neuropathy in Individuals with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Huang X, Bao Y, Wang J, Tian L Rev Cardiovasc Med. 2024; 25(7):244.

PMID: 39139439 PMC: 11317325. DOI: 10.31083/j.rcm2507244.


The Potential of Current Noninvasive Wearable Technology for the Monitoring of Physiological Signals in the Management of Type 1 Diabetes: Literature Survey.

Daskalaki E, Parkinson A, Brew-Sam N, Hossain M, ONeal D, Nolan C J Med Internet Res. 2022; 24(4):e28901.

PMID: 35394448 PMC: 9034434. DOI: 10.2196/28901.

References
1.
Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R . Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011; 27(7):639-53. DOI: 10.1002/dmrr.1239. View

2.
Prince C, Secrest A, Mackey R, Arena V, Kingsley L, Orchard T . Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes. Diabetes Care. 2009; 33(3):652-7. PMC: 2827525. DOI: 10.2337/dc09-1936. View

3.
Tesfaye S, Stevens L, Stephenson J, Fuller J, Plater M, Ionescu-Tirgoviste C . Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996; 39(11):1377-84. DOI: 10.1007/s001250050586. View

4.
Maser R, Mitchell B, Vinik A, Freeman R . The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003; 26(6):1895-901. DOI: 10.2337/diacare.26.6.1895. View

5.
Ziegler D, Gries F, Muhlen H, Rathmann W, Spuler M, Lessmann F . Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabete Metab. 1993; 19(1 Pt 2):143-51. View